The results (Table 2) show that CHEK2 (3.86 [95%CI: 3.1–4.8], p = 7.20 × 10− 23), TP53 (45.05 [95%CI: 23.8–81.8], p = 1.68 × 10− 20), ATM (3.55 [95%CI: 2–5.8.8], p = 7.39 × 10− 5) and KDM1A (4.88 [95% CI: 1.9–10.3], p = 1.48 × 10− 3) were significantly associated with the risk of MM, adjusted for multiple testing correction (Benjamini-Hochberg). This evidence concerns the gene CHEK2 and Miyoshi myopathy.